Sample test report for Vectra CV. Sample test report for Vectra CV. SALT LAKE CITY, Feb. 02, 2021 (GLOBE NEWSWIRE) -- To help more patients with rheumatoid arthritis (RA), Myriad Genetics, Inc.

Results presented today at the American College of Rheumatology in Boston show that a 12-biomarker test did a better job of predicting radiographic progression in patients with RA. The study ...

Vectra DA testing is performed at Crescendo Bioscience’s state-of-the-art CLIA (Clinical Laboratory Improvement Amendments) facility and test results are reported back within 7-10 days of receipt of ...

Rheumatologists commonly use a combination of clinical assessment, x-rays and laboratory tests to help determine the risk of progression of structural damage. Vectra DA represents a novel, precise and ...

Please provide your email address to receive an email when new articles are posted on . The Vectra multi-biomarker disease score, as determined by the Vectra molecular blood test, is a more successful ...

Myriad Genetics, Inc.MYGN recently came up with a favorable study result on the company's adjusted Vectra score. Published in the journal Rheumatology, this study announced results from a large ...

The 12-biomarker test is gaining acceptance among rheumatologists and was recently added to a clinical guideline. Starting Sunday, Crescendo Bioscience will present a series of abstracts on its Vectra ...

Please provide your email address to receive an email when new articles are posted on . The American College of Rheumatology has added the Vectra blood test, developed by Myriad Genetics, to its list ...

SALT LAKE CITY, May 03, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced that it has entered into a definitive agreement to ...

SALT LAKE CITY, Feb. 02, 2021 (GLOBE NEWSWIRE) -- To help more patients with rheumatoid arthritis (RA), Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today ...

Crescendo Bioscience® today announced data indicating that the Company's multi-biomarker blood test for rheumatoid arthritis (RA) disease activity, Vectra TM DA , may more accurately identify RA ...